PT  - JOURNAL ARTICLE
AU  - Matthias Held
AU  - Maria Grün
AU  - Nic Doppert
AU  - Regina Holl
AU  - Franziska Walter
AU  - Manuela Schmidbauer
AU  - Heinrike Wilkens
AU  - Hans-Joachim Schäfers
AU  - Berthold Jany
TI  - Chronic thromboembolic vasculopathy with exercise induced PH but normal resting haemodynamics
DP  - 2014 Sep 01
TA  - European Respiratory Journal
PG  - P2325
VI  - 44
IP  - Suppl 58
4099  - http://erj.ersjournals.com/content/44/Suppl_58/P2325.short
4100  - http://erj.ersjournals.com/content/44/Suppl_58/P2325.full
SO  - Eur Respir J2014 Sep 01; 44
AB  - BackgroundChronic thromboembolic pulmonary hypertension (CTEPH) is defined by chronic thromboembolic vascular obstruction and a mean pulmonary artery pressure (mPAP) of at least 25 mm Hg at rest. It is unclear how to manage symptomatic patients with disturbed lung perfusion due to chronic thromboembolic vascular abnormalities and mPAP below 25 mmHg at rest.Aims:To characterize subjects with mismatched chronic thromboembolic pulmonary perfusion abnormalities and mPAP < 25 mmHg at rest and to compare these subjects with a CTEPH cohort.Methods:We analyzed functional and haemodynamic parameters of 10 subjects with chronic thromboembolic pulmonary vasculopathy but normal mPAP at rest (CTEVP) and 31 CTEPH subjects.Results:CTEVP subjects presented with mPAP at rest of 20 +/- 2 mmHG. mPAP (44 +/-8 mmHg) but not PAWP (8 +/- 4 mmHg) rose under exercise condition. CTEVP subjects showed reduced functional capacity: WHO FC III: 9/10, II 1/10); 76 Watt; VO2 peak (14.8 ml/min/kg; 72 % pred.) Oxygen pulse (101 %) and breathing reserve (30 %) were normal. Dead space ventilation (21%) was elevated. The CTEVP cohort as well as the CTEPH subjects presented with functional signs of disturbed pulmonary perfusion (VE/VCO2: 46.0/49.4 (p=0.53); EQO2AT: 34.0/37.4 (p=0.27); EQCO2AT: 39.2/43.8 (p=0.24) , PETCO2AT: 28.0/27.0 mmHg (p=0.63); PaET CO2 9.3/8.5 mmHg(p=0.58). Only P(A-a)O2 36.1/52.1 mmHg (p=0.04) was significantly different.4/10 CTEVP subjects underwent PEA. Following PEA 3 were asymptomatic, 1 improved from WHO FC III to II.Conclusion:Subjects with dyspnea and CTEVP but normal mPAP below 25mmHg at rest show similar functional limitations as CTEPH patients and can improve significantly following PEA.